C-Codes
C9000–C9999: Outpatient Prospective Payment System
C9000–C9999
- C9014Injection, cerliponase alfa, 1 mg
- C9015Injection, c-1 esterase inhibitor (human), haegarda, 10 units
- C9016Injection, triptorelin extended release, 3.75 mg
- C9021Injection, obinutuzumab, 10 mg
- C9022Injection, elosulfase alfa, 1mg
- C9023Injection, testosterone undecanoate, 1 mg
- C9024Injection, liposomal, 1 mg daunorubicin and 2.27 mg cytarabine
- C9025Injection, ramucirumab, 5 mg
- C9026Injection, vedolizumab, 1 mg
- C9027Injection, pembrolizumab, 1 mg
- C9028Injection, inotuzumab ozogamicin, 0.1 mg
- C9029Injection, guselkumab, 1 mg
- C9030Injection, copanlisib, 1 mg
- C9031Lutetium lu 177, dotatate, therapeutic, 1 mci
- C9032Injection, voretigene neparvovec-rzyl, 1 billion vector genome
- C9033Injection, fosnetupitant 235 mg and palonosetron 0.25 mg
- C9034Injection, dexamethasone 9%, intraocular, 1 mcg
- C9035Injection, aripiprazole lauroxil (aristada initio), 1 mg
- C9036Injection, patisiran, 0.1 mg
- C9037Injection, risperidone (perseris), 0.5 mg
- C9038Injection, mogamulizumab-kpkc, 1 mg
- C9039Injection, plazomicin, 5 mg
- C9040Injection, fremanezumab-vfrm, 1mg
- C9041Injection, coagulation factor xa (recombinant), inactivated (andexxa), 10 mg
- C9042Injection, bendamustine hcl (belrapzo), 1 mg
- C9043Injection, levoleucovorin, 1 mg
- C9044Injection, cemiplimab-rwlc, 1 mg
- C9045Injection, moxetumomab pasudotox-tdfk, 0.01 mg
- C9046Cocaine hydrochloride nasal solution (goprelto), 1 mg
- C9047Injection, caplacizumab-yhdp, 1 mg
- C9048Dexamethasone, lacrimal ophthalmic insert, 0.1 mg
- C9049Injection, tagraxofusp-erzs, 10 mcg
- C9050Injection, emapalumab-lzsg, 1 mg
- C9051Injection, omadacycline, 1 mg
- C9052Injection, ravulizumab-cwvz, 10 mg
- C9053Injection, crizanlizumab-tmca, 1 mg
- C9054Injection, lefamulin (xenleta), 1 mg
- C9055Injection, brexanolone, 1mg
- C9056Injection, givosiran, 0.5 mg
- C9057Injection, cetirizine hydrochloride, 1 mg
- C9058Injection, pegfilgrastim-bmez, biosimilar, (ziextenzo) 0.5 mg
- C9059Injection, meloxicam, 1 mg
- C9060Fluoroestradiol f18, diagnostic, 1 mci
- C9061Injection, teprotumumab-trbw, 10 mg
- C9062Injection, daratumumab 10 mg and hyaluronidase-fihj
- C9063Injection, eptinezumab-jjmr, 1 mg
- C9064Mitomycin pyelocalyceal instillation, 1 mg
- C9065Injection, romidepsin, non-lyophilized (e.g. liquid), 1mg
- C9066Injection, sacituzumab govitecan-hziy, 2.5 mg
- C9067Gallium ga-68, dotatoc, diagnostic, 0.01 mci
- C9068Copper cu-64, dotatate, diagnostic, 1 millicurie
- C9069Injection, belantamab mafodontin-blmf, 0.5 mg
- C9070Injection, tafasitamab-cxix, 2 mg
- C9071Injection, viltolarsen, 10 mg
- C9072Injection, immune globulin (asceniv), 500 mg
- C9073Brexucabtagene autoleucel, up to 200 million autologous anti-cd19 car positive viable t cells, including leukapheresis and dose preparation procedures, per therapeutic dose
- C9074Injection, lumasiran, 0.5 mg
- C9075Injection, casimersen, 10 mg
- C9076Lisocabtagene maraleucel, up to 110 million autologous anti-cd19 car-positive viable t cells, including leukapheresis and dose preparation procedures, per therapeutic dose
- C9077Injection, cabotegravir and rilpivirine, 2mg/3mg
- C9078Injection, trilaciclib, 1 mg
- C9079Injection, evinacumab-dgnb, 5 mg
- C9080Injection, melphalan flufenamide hydrochloride, 1 mg
- C9081Idecabtagene vicleucel, up to 460 million autologous anti-bcma car-positive viable t cells, including leukapheresis and dose preparation procedures, per therapeutic dose
- C9082Injection, dostarlimab-gxly, 100 mg
- C9083Injection, amivantamab-vmjw, 10 mg
- C9084Injection, loncastuximab tesirine-lpyl, 0.1 mg
- C9085Injection, avalglucosidase alfa-ngpt, 4 mg
- C9086Injection, anifrolumab-fnia, 1 mg
- C9087Injection, cyclophosphamide, (auromedics), 10 mg
- C9088Instillation, bupivacaine and meloxicam, 1 mg/0.03 mg
- C9089Bupivacaine, collagen-matrix implant, 1 mg
- C9090Injection, plasminogen, human-tvmh, 1 mg
- C9091Injection, sirolimus protein-bound particles, 1 mg
- C9092Injection, triamcinolone acetonide, suprachoroidal (xipere), 1 mg
- C9093Injection, ranibizumab, via sustained release intravitreal implant (susvimo), 0.1 mg
- C9094Inj, sutimlimab-jome, 10 mg
- C9095Inj, tebentafusp-tebn, 1 mcg
- C9096Injection, filgrastim-ayow, biosimilar, (releuko), 1 microgram
- C9097Inj, faricimab-svoa, 0.1 mg
- C9098Ciltacabtagene autoleucel, up to 100 million autologous b-cell maturation antigen (bcma) directed car-positive t cells, including leukapheresis and dose preparation procedures, per therapeutic dose
- C9101Injection, oliceridine, 0.1 mg
- C9113Injection, pantoprazole sodium, per vial
- C9121Injection, argatroban, per 5 mg
- C9122Mometasone furoate sinus implant, 10 micrograms (sinuva)
- C9132Prothrombin complex concentrate (human), kcentra, per i.u. of factor ix activity
- C9133Factor ix (antihemophilic factor, recombinant), rixubis, per i.u.
- C9134Factor xiii (antihemophilic factor, recombinant), tretten, per 10 i.u.
- C9135Factor ix (antihemophilic factor, recombinant), alprolix, per i.u.
- C9136Injection, factor viii, fc fusion protein, (recombinant), per i.u.
- C9137Injection, factor viii (antihemophilic factor, recombinant) pegylated, 1 i.u.
- C9138Injection, factor viii (antihemophilic factor, recombinant) (nuwiq), 1 i.u.
- C9139Injection, factor ix, albumin fusion protein (recombinant), idelvion, 1 i.u.
- C9140Injection, factor viii (antihemophilic factor, recombinant) (afstyla), 1 i.u.
- C9141Injection, factor viii, (antihemophilic factor, recombinant), pegylated-aucl (jivi), 1 i.u.
- C9142Injection, bevacizumab-maly, biosimilar, (alymsys), 10 mg
- C9143Cocaine hydrochloride nasal solution (numbrino), 1 mg
- C9144Injection, bupivacaine (posimir), 1 mg
- C9145Injection, aprepitant, (aponvie), 1 mg
- C9146Injection, mirvetuximab soravtansine-gynx, 1 mg
- C9147Injection, tremelimumab-actl, 1 mg
- C9148Injection, teclistamab-cqyv, 0.5 mg
- C9149Injection, teplizumab-mzwv, 5 mcg
- C9150Xenon xe-129 hyperpolarized gas, diagnostic, per study dose
- C9151Injection, pegcetacoplan, 1 mg
- C9152Injection, aripiprazole, (abilify asimtufii), 1 mg
- C9153Injection, amisulpride, 1 mg
- C9154Injection, buprenorphine extended-release (brixadi), 1 mg
- C9155Injection, epcoritamab-bysp, 0.16 mg
- C9156Flotufolastat f 18, diagnostic, 1 millicurie
- C9157Injection, tofersen, 1 mg
- C9158Injection, risperidone, (uzedy), 1 mg
- C9159Injection, prothrombin complex concentrate (human), balfaxar, per i.u. of factor ix activity
- C9160Injection, daxibotulinumtoxina-lanm, 1 unit
- C9161Injection, aflibercept hd, 1 mg
- C9162Injection, avacincaptad pegol, 0.1 mg
- C9163Injection, talquetamab-tgvs, 0.25 mg
- C9164Cantharidin for topical administration, 0.7%, single unit dose applicator (3.2 mg)
- C9165Injection, elranatamab-bcmm, 1 mg
- C9166Injection, secukinumab, intravenous, 1 mg
- C9167Injection, adamts13, recombinant-krhn, 10 iu
- C9168Injection, mirikizumab-mrkz, 1 mg
- C9169Injection, nogapendekin alfa inbakicept-pmln, for intravesical use, 1 microgram
- C9170Injection, tarlatamab-dlle, 1 mg
- C9171Injection, pegulicianine, 1 mg
- C9172Injection, fidanacogene elaparvovec-dzkt, per therapeutic dose
- C9173Injection, filgrastim-txid (nypozi), biosimilar, 1 microgram
- C9174Injection, datopotamab deruxtecan-dlnk, 1 mg
- C9175Injection, treosulfan, 50 mg
- C9176Tc-99m from domestically produced non-heu mo-99, [minimum 50 percent], full cost recovery add-on, per study dose
- C9248Injection, clevidipine butyrate, 1 mg
- C9250Human plasma fibrin sealant, vapor-heated, solvent-detergent (artiss), 2 ml
- C9254Injection, lacosamide, 1 mg
- C9257Injection, bevacizumab, 0.25 mg
- C9275Injection, hexaminolevulinate hydrochloride, 100 mg, per study dose
- C9285Lidocaine 70 mg/tetracaine 70 mg, per patch
- C9290Injection, bupivacaine liposome, 1 mg
- C9293Injection, glucarpidase, 10 units
- C9300Injection, indigotindisulfonate sodium, 1 mg
- C9301Obecabtagene autoleucel, up to 400 million cd19 car-positive viable t cells, including leukapheresis and dose preparation procedures, per therapeutic dose
- C9302Injection, zanidatamab-hrii, 2 mg
- C9303Injection, zolbetuximab-clzb, 1 mg
- C9304Injection, marstacimab-hncq, 0.5 mg
- C9305Injection, nipocalimab-aahu, 3 mg
- C9306Injection, telisotuzumab vedotin-tllv, 1 mg
- C9307Injection, linvoseltamab-gcpt, 1 mg
- C9308Injection, carboplatin (avyxa), 1 mg
- C9309Injection, onasemnogene abeparvovec-brve, per treatment
- C9310Injection, leucovorin calcium (avyxa), 1 mg
- C9311Injection, eplontersen, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)
- C9312Injection, trabectedin (apotex), not therapeutically equivalent to j9362, 0.01 mg
- C9313Injection, pivekimab sunirine-pvzy, 0.01 mg
- C9349Puraply, and puraply antimicrobial, any type, per square centimeter
- C9352Microporous collagen implantable tube (neuragen nerve guide), per centimeter length
- C9353Microporous collagen implantable slit tube (neurawrap nerve protector), per centimeter length
- C9354Acellular pericardial tissue matrix of non-human origin (veritas), per square centimeter
- C9355Collagen nerve cuff (neuromatrix), per 0.5 centimeter length
- C9356Tendon, porous matrix of cross-linked collagen and glycosaminoglycan matrix (tenoglide tendon protector sheet), per square centimeter
- C9358Dermal substitute, native, non-denatured collagen, fetal bovine origin (surgimend collagen matrix), per 0.5 square centimeters
- C9359Porous purified collagen matrix bone void filler (integra mozaik osteoconductive scaffold putty, integra os osteoconductive scaffold putty), per 0.5 cc
- C9360Dermal substitute, native, non-denatured collagen, neonatal bovine origin (surgimend collagen matrix), per 0.5 square centimeters
- C9361Collagen matrix nerve wrap (neuromend collagen nerve wrap), per 0.5 centimeter length
- C9362Porous purified collagen matrix bone void filler (integra mozaik osteoconductive scaffold strip), per 0.5 cc
- C9363Skin substitute, integra meshed bilayer wound matrix, per square centimeter
- C9364Porcine implant, permacol, per square centimeter
- C9399Unclassified drugs or biologicals
- C9407Iodine i-131 iobenguane, diagnostic, 1 millicurie
- C9408Iodine i-131 iobenguane, therapeutic, 1 millicurie
- C9441Injection, ferric carboxymaltose, 1 mg
- C9442Injection, belinostat, 10 mg
- C9443Injection, dalbavancin, 10 mg
- C9444Injection, oritavancin, 10 mg
- C9445Injection, c-1 esterase inhibitor (recombinant), ruconest, 10 units
- C9446Injection, tedizolid phosphate, 1 mg
- C9447Injection, phenylephrine and ketorolac, 4 ml vial
- C9448Netupitant 300 mg and palonosetron 0.5 mg, oral
- C9449Injection, blinatumomab, 1 mcg
- C9450Injection, fluocinolone acetonide intravitreal implant, 0.01 mg
- C9451Injection, peramivir, 1 mg
- C9452Injection, ceftolozane 50 mg and tazobactam 25 mg
- C9453Injection, nivolumab, 1 mg
- C9454Injection, pasireotide long acting, 1 mg
- C9455Injection, siltuximab, 10 mg
- C9456Injection, isavuconazonium sulfate, 1 mg
- C9457Injection, sulfur hexafluoride lipid microsphere, per ml
- C9458Florbetaben f18, diagnostic, per study dose, up to 8.1 millicuries
- C9459Flutemetamol f18, diagnostic, per study dose, up to 5 millicuries
- C9460Injection, cangrelor, 1 mg
- C9461Choline c 11, diagnostic, per study dose
- C9462Injection, delafloxacin, 1 mg
- C9463Injection, aprepitant, 1 mg
- C9464Injection, rolapitant, 0.5 mg
- C9465Hyaluronan or derivative, durolane, for intra-articular injection, per dose
- C9466Injection, benralizumab, 1 mg
- C9467Injection, rituximab and hyaluronidase, 10 mg
- C9468Injection, factor ix (antihemophilic factor, recombinant), glycopegylated, rebinyn, 1 i.u.
- C9469Injection, triamcinolone acetonide, preservative-free, extended-release, microsphere formulation, 1 mg
- C9470Injection, aripiprazole lauroxil, 1 mg
- C9471Hyaluronan or derivative, hymovis, for intra-articular injection, 1 mg
- C9472Injection, talimogene laherparepvec, 1 million plaque forming units (pfu)
- C9473Injection, mepolizumab, 1 mg
- C9474Injection, irinotecan liposome, 1 mg
- C9475Injection, necitumumab, 1 mg
- C9476Injection, daratumumab, 10 mg
- C9477Injection, elotuzumab, 1 mg
- C9478Injection, sebelipase alfa, 1 mg
- C9479Instillation, ciprofloxacin otic suspension, 6 mg
- C9480Injection, trabectedin, 0.1 mg
- C9481Injection, reslizumab, 1 mg
- C9482Injection, sotalol hydrochloride, 1 mg
- C9483Injection, atezolizumab, 10 mg
- C9484Injection, eteplirsen, 10 mg
- C9485Injection, olaratumab, 10 mg
- C9486Injection, granisetron extended release, 0.1 mg
- C9487Ustekinumab, for intravenous injection, 1 mg
- C9488Injection, conivaptan hydrochloride, 1 mg
- C9489Injection, nusinersen, 0.1 mg
- C9490Injection, bezlotoxumab, 10 mg
- C9491Injection, avelumab, 10 mg
- C9492Injection, durvalumab, 10 mg
- C9493Injection, edaravone, 1 mg
- C9494Injection, ocrelizumab, 1 mg
- C9497Loxapine, inhalation powder, 10 mg
- C9507Plasma, high titer covid-19 convalescent, each unit
- C9600Percutaneous transcatheter placement of drug eluting intracoronary stent(s), with coronary angioplasty when performed; single major coronary artery or branch
- C9601Percutaneous transcatheter placement of drug-eluting intracoronary stent(s), with coronary angioplasty when performed; each additional branch of a major coronary artery (list separately in addition to code for primary procedure)
- C9602Percutaneous transluminal coronary atherectomy, with drug eluting intracoronary stent, with coronary angioplasty when performed; single major coronary artery or branch
- C9603Percutaneous transluminal coronary atherectomy, with drug-eluting intracoronary stent, with coronary angioplasty when performed; each additional branch of a major coronary artery (list separately in addition to code for primary procedure)
- C9604Percutaneous transluminal revascularization of or through coronary artery bypass graft (internal mammary, free arterial, venous), any combination of drug-eluting intracoronary stent, atherectomy and angioplasty, including distal protection when performed; single vessel
- C9605Percutaneous transluminal revascularization of or through coronary artery bypass graft (internal mammary, free arterial, venous), any combination of drug-eluting intracoronary stent, atherectomy and angioplasty, including distal protection when performed; each additional branch subtended by the bypass graft (list separately in addition to code for primary procedure)
- C9606Percutaneous transluminal revascularization of acute total/subtotal occlusion during acute myocardial infarction, coronary artery or coronary artery bypass graft, any combination of drug-eluting intracoronary stent, atherectomy and angioplasty, including aspiration thrombectomy when performed, single vessel
- C9607Percutaneous transluminal revascularization of chronic total occlusion, coronary artery, coronary artery branch, or coronary artery bypass graft, any combination of drug-eluting intracoronary stent, atherectomy and angioplasty; single vessel
- C9608Percutaneous transluminal revascularization of chronic total occlusion, coronary artery, coronary artery branch, or coronary artery bypass graft, any combination of drug-eluting intracoronary stent, atherectomy and angioplasty; each additional coronary artery, coronary artery branch, or bypass graft (list separately in addition to code for primary procedure)
- C9610Catheter, transluminal drug delivery with or without angioplasty, coronary, non-laser (insertable)
- C9724Endoscopic full-thickness plication of the stomach using endoscopic plication system (eps); includes endoscopy
- C9725Placement of endorectal intracavitary applicator for high intensity brachytherapy
- C9726Placement and removal (if performed) of applicator into breast for intraoperative radiation therapy, add-on to primary breast procedure
- C9727Insertion of implants into the soft palate; minimum of three implants
- C9728Placement of interstitial device(s) for radiation therapy/surgery guidance (e.g., fiducial markers, dosimeter), for other than the following sites (any approach): abdomen, pelvis, prostate, retroperitoneum, thorax, single or multiple
- C9733Non-ophthalmic fluorescent vascular angiography
- C9734Focused ultrasound ablation/therapeutic intervention, other than uterine leiomyomata, with magnetic resonance (mr) guidance
- C9735Anoscopy; with directed submucosal injection(s), any substance
- C9737Laparoscopy, surgical, esophageal sphincter augmentation with device (e.g., magnetic band)
- C9738Adjunctive blue light cystoscopy with fluorescent imaging agent (list separately in addition to code for primary procedure)
- C9739Cystourethroscopy, with insertion of transprostatic implant; 1 to 3 implants
- C9740Cystourethroscopy, with insertion of transprostatic implant; 4 or more implants
- C9741Right heart catheterization with implantation of wireless pressure sensor in the pulmonary artery, including any type of measurement, angiography, imaging supervision, interpretation, and report
- C9742Laryngoscopy, flexible fiberoptic, with injection into vocal cord(s), therapeutic, including diagnostic laryngoscopy, if performed
- C9743Injection/implantation of bulking or spacer material (any type) with or without image guidance (not to be used if a more specific code applies)
- C9744Ultrasound, abdominal, with contrast
- C9745Nasal endoscopy, surgical; balloon dilation of eustachian tube
- C9746Transperineal implantation of permanent adjustable balloon continence device, with cystourethroscopy, when performed and/or fluoroscopy, when performed
- C9747Ablation of prostate, transrectal, high intensity focused ultrasound (hifu), including imaging guidance
- C9748Transurethral destruction of prostate tissue; by radiofrequency water vapor (steam) thermal therapy
- C9749Repair of nasal vestibular lateral wall stenosis with implant(s)
- C9750Insertion or removal and replacement of intracardiac ischemia monitoring system including imaging supervision and interpretation and peri-operative interrogation and programming; complete system (includes device and electrode)
- C9751Bronchoscopy, rigid or flexible, transbronchial ablation of lesion(s) by microwave energy, including fluoroscopic guidance, when performed, with computed tomography acquisition(s) and 3-d rendering, computer-assisted, image-guided navigation, and endobronchial ultrasound (ebus) guided transtracheal and/or transbronchial sampling (e.g., aspiration[s]/biopsy[ies]) and all mediastinal and/or hilar lymph node stations or structures and therapeutic intervention(s)
- C9752Destruction of intraosseous basivertebral nerve, first two vertebral bodies, including imaging guidance (e.g., fluoroscopy), lumbar/sacrum
- C9753Destruction of intraosseous basivertebral nerve, each additional vertebral body, including imaging guidance (e.g., fluoroscopy), lumbar/sacrum (list separately in addition to code for primary procedure)
- C9754Creation of arteriovenous fistula, percutaneous; direct, any site, including all imaging and radiologic supervision and interpretation, when performed and secondary procedures to redirect blood flow (e.g., transluminal balloon angioplasty, coil embolization, when performed)
- C9755Creation of arteriovenous fistula, percutaneous using magnetic-guided arterial and venous catheters and radiofrequency energy, including flow-directing procedures (e.g., vascular coil embolization with radiologic supervision and interpretation, when performed) and fistulogram(s), angiography, venography, and/or ultrasound, with radiologic supervision and interpretation, when performed
- C9756Intraoperative near-infrared fluorescence lymphatic mapping of lymph node(s) (sentinel or tumor draining) with administration of indocyanine green (icg) (list separately in addition to code for primary procedure)
- C9757Laminotomy (hemilaminectomy), with decompression of nerve root(s), including partial facetectomy, foraminotomy and excision of herniated intervertebral disc, and repair of annular defect with implantation of bone anchored annular closure device, including annular defect measurement, alignment and sizing assessment, and image guidance; 1 interspace, lumbar
- C9758Blinded procedure for nyha class iii/iv heart failure; transcatheter implantation of interatrial shunt or placebo control, including right heart catheterization, trans-esophageal echocardiography (tee)/intracardiac echocardiography (ice), and all imaging with or without guidance (e.g., ultrasound, fluoroscopy), performed in an approved investigational device exemption (ide) study
- C9759Transcatheter intraoperative blood vessel microinfusion(s) (e.g., intraluminal, vascular wall and/or perivascular) therapy, any vessel, including radiological supervision and interpretation, when performed
- C9760Non-randomized, non-blinded procedure for nyha class ii, iii, iv heart failure; transcatheter implantation of interatrial shunt, including right and left heart catheterization, transeptal puncture, trans-esophageal echocardiography (tee)/intracardiac echocardiography (ice), and all imaging with or without guidance (e.g., ultrasound, fluoroscopy), performed in an approved investigational device exemption (ide) study
- C9761Cystourethroscopy, with ureteroscopy and/or pyeloscopy, with lithotripsy, and ureteral catheterization for steerable vacuum aspiration of the kidney, collecting system, ureter, bladder, and urethra if necessary, with use of steerable ureteral catheter or suction-integrated ureteroscope
- C9762Cardiac magnetic resonance imaging for morphology and function, quantification of segmental dysfunction; with strain imaging
- C9763Cardiac magnetic resonance imaging for morphology and function, quantification of segmental dysfunction; with stress imaging
- C9764Revascularization, endovascular, open or percutaneous, lower extremity artery(ies), except tibial/peroneal; with intravascular lithotripsy, includes angioplasty within the same vessel(s), when performed
- C9765Revascularization, endovascular, open or percutaneous, lower extremity artery(ies), except tibial/peroneal; with intravascular lithotripsy, and transluminal stent placement(s), includes angioplasty within the same vessel(s), when performed
- C9766Revascularization, endovascular, open or percutaneous, lower extremity artery(ies), except tibial/peroneal; with intravascular lithotripsy and atherectomy, includes angioplasty within the same vessel(s), when performed
- C9767Revascularization, endovascular, open or percutaneous, lower extremity artery(ies), except tibial/peroneal; with intravascular lithotripsy and transluminal stent placement(s), and atherectomy, includes angioplasty within the same vessel(s), when performed
- C9768Endoscopic ultrasound-guided direct measurement of hepatic portosystemic pressure gradient by any method (list separately in addition to code for primary procedure)
- C9769Cystourethroscopy, with insertion of temporary prostatic implant/stent with fixation/anchor and incisional struts
- C9770Vitrectomy, mechanical, pars plana approach, with subretinal injection of pharmacologic/biologic agent
- C9771Nasal/sinus endoscopy, cryoablation nasal tissue(s) and/or nerve(s), unilateral or bilateral
- C9772Revascularization, endovascular, open or percutaneous, tibial/peroneal artery(ies), with intravascular lithotripsy, includes angioplasty within the same vessel (s), when performed
- C9773Revascularization, endovascular, open or percutaneous, tibial/peroneal artery(ies); with intravascular lithotripsy, and transluminal stent placement(s), includes angioplasty within the same vessel(s), when performed
- C9774Revascularization, endovascular, open or percutaneous, tibial/peroneal artery(ies); with intravascular lithotripsy and atherectomy, includes angioplasty within the same vessel (s), when performed
- C9775Revascularization, endovascular, open or percutaneous, tibial/peroneal artery(ies); with intravascular lithotripsy and transluminal stent placement(s), and atherectomy, includes angioplasty within the same vessel (s), when performed
- C9776Intraoperative near-infrared fluorescence imaging of major extra-hepatic bile duct(s) (e.g., cystic duct, common bile duct and common hepatic duct) with intravenous administration of indocyanine green (icg) (list separately in addition to code for primary procedure)
- C9777Esophageal mucosal integrity testing by electrical impedance, transoral, includes esophagoscopy or esophagogastroduodenoscopy
- C9778Colpopexy, vaginal; minimally invasive extra-peritoneal approach (sacrospinous)
- C9779Endoscopic submucosal dissection (esd), including endoscopy or colonoscopy, mucosal closure, when performed
- C9780Insertion of central venous catheter through central venous occlusion via inferior and superior approaches (e.g., inside-out technique), including imaging guidance
- C9781Arthroscopy, shoulder, surgical; with implantation of subacromial spacer (e.g., balloon), includes debridement (e.g., limited or extensive), subacromial decompression, acromioplasty, and biceps tenodesis when performed
- C9782Blinded procedure for new york heart association (nyha) class ii or iii heart failure, or canadian cardiovascular society (ccs) class iii or iv chronic refractory angina; transcatheter intramyocardial transplantation of autologous bone marrow cells (e.g., mononuclear) or placebo control, autologous bone marrow harvesting and preparation for transplantation, left heart catheterization including ventriculography, all laboratory services, and all imaging with or without guidance (e.g., transthoracic echocardiography, ultrasound, fluoroscopy), performed in an approved investigational device exemption (ide) study
- C9783Blinded procedure for transcatheter implantation of coronary sinus reduction device or placebo control, including vascular access and closure, right heart catheterization, venous and coronary sinus angiography, imaging guidance and supervision and interpretation when performed in an approved investigational device exemption (ide) study
- C9784Gastric restrictive procedure, endoscopic sleeve gastroplasty, with esophagogastroduodenoscopy and intraluminal tube insertion, if performed, including all system and tissue anchoring components
- C9785Endoscopic outlet reduction, gastric pouch application, with endoscopy and intraluminal tube insertion, if performed, including all system and tissue anchoring components
- C9786Echocardiography image post processing for computer aided detection of heart failure with preserved ejection fraction, including interpretation and report
- C9787Gastric electrophysiology mapping with simultaneous patient symptom profiling
- C9788Opto-acoustic imaging, breast (including axilla when performed), unilateral, with image documentation, analysis and report, obtained with ultrasound examination
- C9789Instillation of anti-neoplastic pharmacologic/biologic agent into renal pelvis, any method, including all imaging guidance, including volumetric measurement if performed
- C9790Histotripsy (i.e., non-thermal ablation via acoustic energy delivery) of malignant renal tissue, including image guidance
- C9791Magnetic resonance imaging with inhaled hyperpolarized xenon-129 contrast agent, chest, including preparation and administration of agent
- C9792Blinded or nonblinded procedure for symptomatic new york heart association (nyha) class ii, iii, iva heart failure; transcatheter implantation of left atrial to coronary sinus shunt using jugular vein access, including all imaging necessary to intra procedurally map the coronary sinus for optimal shunt placement (e.g., tee or ice ultrasound, fluoroscopy), performed under general anesthesia in an approved investigational device exemption (ide) study)
- C97933d predictive model generation for pre-planning of a cardiac procedure, using data from cardiac computed tomographic angiography and/or magnetic resonance imaging with report
- C9794Therapeutic radiology simulation-aided field setting; complex, including acquisition of pet and ct imaging data required for radiopharmaceutical-directed radiation therapy treatment planning (i.e., modeling)
- C9795Stereotactic body radiation therapy, treatment delivery, per fraction to 1 or more lesions, including image guidance and real-time positron emissions-based delivery adjustments to 1 or more lesions, entire course not to exceed 5 fractions
- C9796Repair of enterocutaneous fistula small intestine or colon (excluding anorectal fistula) with plug (e.g., porcine small intestine submucosa [sis])
- C9797Vascular embolization or occlusion procedure with use of a pressure-generating catheter (e.g., one-way valve or occlusion balloon, intermittently or temporarily occluding), inclusive of all radiological supervision and interpretation, intraprocedural roadmapping, and imaging guidance necessary to complete the intervention; for tumors, organ ischemia, or infarction
- C9800Dermal injection procedure(s) for facial lipodystrophy syndrome (lds) and provision of radiesse or sculptra dermal filler, including all items and supplies
- C9803Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source
- C9804Elastomeric infusion pump (e.g., on-q* pump with bolus), including catheter and all disposable system components, non-opioid medical device (must be a qualifying medicare non-opioid medical device for post-surgical pain relief in accordance with section 4135 of the caa, 2023)
- C9806Rotary peristaltic infusion pump (e.g., ambit pump), including catheter and all disposable system components, non-opioid medical device (must be a qualifying medicare non-opioid medical device for post-surgical pain relief in accordance with section 4135 of the caa, 2023)
- C9807Nerve stimulator, percutaneous, peripheral (e.g., sprint peripheral nerve stimulation system), including electrode and all disposable system components, non-opioid medical device (must be a qualifying medicare non-opioid medical device for post-surgical pain relief in accordance with section 4135 of the caa, 2023)
- C9808Nerve cryoablation probe (e.g., cryoice, cryosphere, cryosphere max, cryoice cryosphere, cryoice cryo2), including probe and all disposable system components, non-opioid medical device (must be a qualifying medicare non-opioid medical device for post-surgical pain relief in accordance with section 4135 of the caa, 2023)
- C9809Cryoneurolysis needle (e.g., iovera system), including needle/tip and all disposable system components, non-opioid medical device (must be a qualifying medicare non-opioid medical device for post-surgical pain relief in accordance with section 4135 of the caa, 2023)
- C9810Water circulating motorized cold therapy device (e.g., iceman) including all system components (e.g. pads, console, disposable parts), non-opioid medical device (must be a qualifying medicare non-opioid medical device for post-surgical pain relief in accordance with section 4135 of the caa, 2023)
- C9811Electronic ambulatory infusion pump (e.g. sapphire pump), including all pump components, including disposable components , non-opioid medical device (must be a qualifying medicare non-opioid medical device for post-surgical pain relief in accordance with section 4135 of the caa, 2023)
- C9812Echogenic and/or nerve stimulator-guided nerve block needles (e.g. sonoplex, sonoblock, sonotap, stimuplex), non-opioid medical device (must be a qualifying medicare non-opioid medical device for post-surgical pain relief in accordance with section 4135 of the caa, 2023)
- C9813Perforated continuous infusion catheter set (e.g. infiltralong), including all components, non-opioid medical device (must be a qualifying medicare non-opioid medical device for post-surgical pain relief in accordance with section 4135 of the caa, 2023)
- C9814Continuous anesthesia echogenic conduction catheter set (e.g. sonolong, e-cath), including all components, non-opioid medical device (must be a qualifying medicare non-opioid medical device for post-surgical pain relief in accordance with section 4135 of the caa, 2023)
- C9815Linear peristaltic pain management infusion pump (e.g. cadd-solis ambulatory infusion pump), and all disposable system components, non-opioid medical device (must be a qualifying medicare non-opioid medical device for post-surgical pain relief in accordance with section 4135 of the caa, 2023)
- C9816Rotary peristaltic infusion pump (e.g., reusable ambit pump) including all disposable system components, reusable non-opioid medical device (must be a qualifying medicare non-opioid medical device for post-surgical pain relief in accordance with section 4135 of the caa, 2023)
- C9817Electronic cryo-pneumatic compression, pain management system (e.g. game ready grpro 2.1 system), including control unit, anatomically correct wrap(s), and other system component(s), non-opioid medical device (must be a qualifying medicare non-opioid medical device for post-surgical pain relief in accordance with section 4135 of the caa, 2023)
- C9818Suzetrigine, oral, 1 mg
- C9898Radiolabeled product provided during a hospital inpatient stay
- C9899Implanted prosthetic device, payable only for inpatients who do not have inpatient coverage
- C9901Endoscopic defect closure within the entire gastrointestinal tract, including upper endoscopy (including diagnostic, if performed) or colonoscopy (including diagnostic, if performed), with all system and tissue anchoring components